ES2002508A6 - New sustained-release formulation based on pindolol - Google Patents

New sustained-release formulation based on pindolol

Info

Publication number
ES2002508A6
ES2002508A6 ES8602313A ES8602313A ES2002508A6 ES 2002508 A6 ES2002508 A6 ES 2002508A6 ES 8602313 A ES8602313 A ES 8602313A ES 8602313 A ES8602313 A ES 8602313A ES 2002508 A6 ES2002508 A6 ES 2002508A6
Authority
ES
Spain
Prior art keywords
pindolol
release formulation
formulation based
new sustained
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8602313A
Other languages
Spanish (es)
Inventor
Othmar Zuger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2002508A6 publication Critical patent/ES2002508A6/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention relates to a sustained-release formulation for oral administration, comprising a substance chosen from pindolol and an ester of 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydroxy-2,6-dimethyl- 3,5-pyridinedicarboxylic acid, a pharmaceutically acceptable hydrophilic swelling substance and optionally a pharmaceutically acceptable inert fat.
ES8602313A 1985-10-01 1986-09-30 New sustained-release formulation based on pindolol Expired ES2002508A6 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2002508A6 true ES2002508A6 (en) 1988-08-16

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8602313A Expired ES2002508A6 (en) 1985-10-01 1986-09-30 New sustained-release formulation based on pindolol

Country Status (20)

Country Link
KR (1) KR920008817B1 (en)
AT (1) AT402257B (en)
BE (1) BE905516A (en)
CA (1) CA1298784C (en)
CH (1) CH669524A5 (en)
DE (1) DE3632201C2 (en)
DK (1) DK170016B1 (en)
ES (1) ES2002508A6 (en)
FR (1) FR2589732B1 (en)
GR (1) GR862457B (en)
HK (1) HK392A (en)
HU (1) HU197201B (en)
IE (1) IE59589B1 (en)
IL (1) IL80182A (en)
LU (1) LU86615A1 (en)
NL (1) NL194822C (en)
NZ (1) NZ217732A (en)
PT (1) PT83456B (en)
SE (1) SE503222C2 (en)
SG (1) SG103391G (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ATE409475T1 (en) * 2001-02-20 2008-10-15 Dinan Timothy Gerard TREATING FIBROMYALGIA WITH PINDOLOL
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
DD145004A3 (en) * 1978-09-25 1980-11-19 Reinhard Huettenrauch METHOD FOR PRODUCING SOLID A NOMENCLATES
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (en) * 1980-05-21 1985-12-09 塩野義製薬株式会社 sustained release formulation
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6124516A (en) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd Long active tablet

Also Published As

Publication number Publication date
KR870003777A (en) 1987-05-04
SG103391G (en) 1992-01-17
KR920008817B1 (en) 1992-10-09
IE59589B1 (en) 1994-03-09
SE503222C2 (en) 1996-04-22
IL80182A (en) 1991-01-31
NL194822C (en) 2003-04-03
IE862565L (en) 1987-04-01
DK170016B1 (en) 1995-05-01
HK392A (en) 1992-01-10
FR2589732B1 (en) 1989-07-13
NZ217732A (en) 1990-07-26
DE3632201A1 (en) 1987-04-02
NL8602370A (en) 1987-05-04
FR2589732A1 (en) 1987-05-15
CA1298784C (en) 1992-04-14
SE8604112L (en) 1987-04-02
HUT44701A (en) 1988-04-28
GR862457B (en) 1987-01-29
DK464686D0 (en) 1986-09-29
ATA260486A (en) 1996-08-15
PT83456A (en) 1986-10-01
HU197201B (en) 1989-03-28
LU86615A1 (en) 1987-04-02
AT402257B (en) 1997-03-25
CH669524A5 (en) 1989-03-31
PT83456B (en) 1989-05-12
DE3632201C2 (en) 1997-05-07
IL80182A0 (en) 1986-12-31
NL194822B (en) 2002-12-02
SE8604112D0 (en) 1986-09-29
DK464686A (en) 1987-04-02
BE905516A (en) 1987-03-30

Similar Documents

Publication Publication Date Title
ES479474A1 (en) Use of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3-beta-methoxy ethylester-5-isopropylester for the preparation of cerebrally active drugs.
GR3004509T3 (en)
NO883667L (en) Capsule for pharmaceutically active ingredients of a drug.
AU7192287A (en) Pharmaceutical formulations of acid labile substances for oral use
DE69206345D1 (en) Intranasal drugs containing Ketorolac R.
MY108496A (en) Hypoglycemic thiazolidine diones.
OA09415A (en) "Pharmaceutical composition for oral administration based on a derivative of diphosphonic acid".
DK0510404T3 (en) Gastroresistant pharmaceutical formulations for oral administration containing bile acid salts
AU2766689A (en) New pharmaceutical formulations with programmed release
PH21591A (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition
BE893193A (en) PHARMACEUTICAL COMPOSITION CONTAINING 24-25-DIHYDROXY-CHOLECALCIFEROL AS ACTIVE INGREDIENT
DE3585107D1 (en) SOLID DRUG PREPARATIONS WITH DIHYDROPYRIDINE AND METHOD FOR THE PRODUCTION THEREOF.
PT83241A (en) Process for preparing drug-polymer matrix compositions capable of masking the taste of an active ingredient containing a copolymer having a plurality of carboxylic acid and ester groups
FR2618670B1 (en) MEDICINAL PREPARATION BASED ON ESSENTIAL OILS, AS WELL AS DENTAL AND CHEWING GUM CONTAINING THE SAME
AU1269488A (en) Phenoxycarboxylic acid and herbicide comprising it as active ingredient
ES2002508A6 (en) New sustained-release formulation based on pindolol
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
AU2617288A (en) Pharmaceutical formulations for transdermal administration
FI884611A (en) Process for the preparation of a pharmaceutical composition of - [4- (1,1-dimethylethyl) phenyl] -4- (hydroxydiphenylmethyl) -1-piperidinebutanol
AU7536487A (en) A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
NZ229023A (en) 1,1-dioxo-cephem-4-carbothiolic acid derivatives, pharmaceutical compositions and methods of preparation
ES8801543A1 (en) 1,4-Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions containing same.
EP0238198A3 (en) Method of modifying the lipid structure function and expression of cell membranes and pharmaceutical compositions for use therein
IT1214719B (en) Controlled release cardiovascular preparations
ZA876716B (en) Pharmaceutical composition containing a 1,4-dihydropyridine derivative and an acylated 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2006-09-30

PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20061002